Acessibilidade / Reportar erro

EFFECT OF CREATINE AND SILDENAFIL CITRATE ON THE PHYSICAL PERFORMANCE OF MICE

EFECTO DE LA CREATINA Y DEL CITRATO DE SILDENAFIL SOBRE EL DESEMPEÑO FÍSICO DE RATONES

ABSTRACT

Introduction:

The use of substances to enhance sports performance among professional and amateur athletes is increasing. Such substances may either be included in the group of dietary supplements or fall into pharmacological classes. Every substance used for this purpose is called an ergogenic agent. The number of ergogenic options available increases every day, favoring overuse and use without proper guidance. Among the dietary supplements, we highlight the use of creatine, a substance widespread in sports. Among the pharmacological groups, many drugs are used. Recently the use of sildenafil citrate by professional athletes from various predominantly aerobic sports modalities was reported in the media.

Objective:

To compare and demonstrate the responses caused by physical training associated with the use of creatine and sildenafil citrate in mice.

Methods:

A swim training protocol was applied and then an electrophysiograph was used in order to obtain parameters related to contraction intensity, the area under the curve and the percentage drop.

Results:

The responses obtained demonstrated the ergogenic action of creatine because it altered the parameters used for measurement. The use of sildenafil citrate did not yield satisfactory results to frame the drug as an ergogenic agent.

Conclusion:

Creatine has an ergogenic effect, reducing the percentage drop after 10 seconds, while sildenafil demonstrated no ergogenic potential and, interestingly, resulted in weaker responses when compared to the exercise groups. Evidence level II; Comparative prospective study .

Keywords:
Creatine; Muscle fatigue; Sildenafil citrate

Sociedade Brasileira de Medicina do Exercício e do Esporte Av. Brigadeiro Luís Antônio, 278, 6º and., 01318-901 São Paulo SP, Tel.: +55 11 3106-7544, Fax: +55 11 3106-8611 - São Paulo - SP - Brazil
E-mail: atharbme@uol.com.br